Chabiotech Co.,Ltd. (085660.KQ)
KRW 15280.0
(-2.98%)
KRW 15280.0
(-2.98%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 285.93 Billion KRW | 8.97% |
| 2022 | 242.83 Billion KRW | 22.35% |
| 2021 | 198.47 Billion KRW | 7.32% |
| 2020 | 184.93 Billion KRW | 12.18% |
| 2019 | 164.85 Billion KRW | 13.42% |
| 2018 | 145.34 Billion KRW | 11.47% |
| 2017 | 130.38 Billion KRW | 18.94% |
| 2016 | 109.62 Billion KRW | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 67.33 Billion KRW | 15.41% |
| 2024 Q1 | 64.36 Billion KRW | -12.45% |
| 2023 FY | 264.61 Billion KRW | 8.97% |
| 2023 Q2 | 65.43 Billion KRW | 9.61% |
| 2023 Q3 | 66.14 Billion KRW | 1.09% |
| 2023 Q4 | 73.51 Billion KRW | 11.15% |
| 2023 Q1 | 59.69 Billion KRW | -19.74% |
| 2022 Q2 | 58.36 Billion KRW | 11.13% |
| 2022 FY | 242.83 Billion KRW | 22.35% |
| 2022 Q4 | 74.37 Billion KRW | 29.18% |
| 2022 Q3 | 57.57 Billion KRW | -1.36% |
| 2022 Q1 | 52.51 Billion KRW | -6.18% |
| 2021 Q4 | 55.97 Billion KRW | 34.38% |
| 2021 FY | 198.47 Billion KRW | 7.32% |
| 2021 Q3 | 41.65 Billion KRW | 0.0% |
| 2020 FY | 184.93 Billion KRW | 12.18% |
| 2019 FY | 164.85 Billion KRW | 13.42% |
| 2018 FY | 145.34 Billion KRW | 11.47% |
| 2017 FY | 130.38 Billion KRW | 18.94% |
| 2016 FY | 109.62 Billion KRW | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| HLB Co., Ltd. | 109.98 Billion KRW | -159.976% |
| iNtRON Biotechnology, Inc. | 7.84 Billion KRW | -3544.474% |
| BINEX Co., Ltd. | 55.67 Billion KRW | -413.579% |
| Bioneer Corporation | 204.55 Billion KRW | -39.783% |
| Anterogen.Co.,Ltd. | 7.74 Billion KRW | -3594.214% |
| MEDIPOST Co., Ltd. | 65.31 Billion KRW | -337.786% |
| CrystalGenomics, Inc. | 32.36 Billion KRW | -783.347% |
| Helixmith Co., Ltd | 37.36 Billion KRW | -665.213% |
| Medy-Tox Inc. | 110.88 Billion KRW | -157.869% |
| Peptron, Inc. | 16.65 Billion KRW | -1616.675% |
| Amicogen, Inc. | 52.82 Billion KRW | -441.312% |
| Genexine, Inc. | 41.62 Billion KRW | -586.886% |
| HLB Therapeutics Co.,Ltd. | 16.16 Billion KRW | -1668.715% |
| LegoChem Biosciences, Inc. | 98.61 Billion KRW | -189.942% |
| ALTEOGEN Inc. | 40.93 Billion KRW | -598.514% |
| PharmaResearch Co., Ltd. | 89.44 Billion KRW | -219.696% |
| SillaJen, Inc. | 5.11 Billion KRW | -5493.218% |
| JETEMA, Co., Ltd. | 25.66 Billion KRW | -1014.149% |
| OliX Pharmaceuticals,Inc | 35.24 Billion KRW | -711.184% |
| Genomictree Inc. | 16.26 Billion KRW | -1658.016% |
| MedPacto, Inc. | 26.91 Billion KRW | -962.205% |
| D&D Pharmatech | 32.16 Billion KRW | -789.024% |
| EASY BIO,Inc. | 29.67 Billion KRW | -863.668% |
| GI Innovation, Inc. | 57.59 Billion KRW | -396.482% |